Neurology

Nobel Prize optogenetics delivers millisecond control over brain circuits, unlocking targeted therapies for chronic brain diseases.

Adjunctive low-dose IL-2 for ALS significantly improved overall survival while reducing functional decline across targeted cohorts.

Recent FDA approval establishes the first Sanfilippo syndrome gene therapy treatment despite significant confidential product cost.

Glucosamine supplements accelerate dementia progression and increase mortality risk in older adults, according to recent research.

Neuromuscular junction failure causes severe muscle weakness in sarcopenia by reducing postsynaptic endplate action potential gain.

Meningitis mortality declined markedly across three decades, but recent outbreaks show global progress remains severely off course.

Measles outbreaks raise clinical concern over fatal neurological persistence driven by adaptive viral mutations in the human brain.

Post-traumatic headache predominantly mirrors migraine, but standard therapies frequently fail to provide adequate clinical relief.